首页> 美国卫生研究院文献>Case Reports in Rheumatology >Clinical Utility of Neutrophil CD64 to Detect Extrapulmonary Tuberculosis in Three Patients with Rheumatoid Arthritis Undergoing Treatment with Biologics
【2h】

Clinical Utility of Neutrophil CD64 to Detect Extrapulmonary Tuberculosis in Three Patients with Rheumatoid Arthritis Undergoing Treatment with Biologics

机译:中性粒细胞CD64在三例接受生物制剂治疗的类风湿关节炎患者中检测肺外结核的临床效用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Biologics play a key role in the treatment of rheumatoid arthritis (RA), while RA-related serious infection remains an unsettled clinical problem. Detection of tuberculosis (TB) is challenging due to the difficulty in distinguishing symptoms such as fever and elevation of inflammatory markers from other infections or a disease flare of RA. The expression of the CD64 molecule on neutrophils (neutrophil CD64) was upregulated by various infections including TB. However, it was not affected by disease activity of RA or by any therapy against RA. The present article reports three cases of extrapulmonary TB which occurred in patients with RA undergoing treatment with biologics. The marked increase in the levels of neutrophil CD64 may provide important insight into the diagnosis of TB.
机译:生物制剂在类风湿关节炎(RA)的治疗中起着关键作用,而与RA有关的严重感染仍然是一个尚未解决的临床问题。由于难以区分症状,例如发烧和炎症标志物升高与其他感染或RA的疾病发作,因此结核病(TB)的检测具有挑战性。 CD64分子在嗜中性粒细胞(neutrophil CD64)上的表达被包括TB在内的各种感染上调。然而,它不受RA的疾病活性或任何针对RA的疗法的影响。本文报道了三例肺外结核,发生在接受生物制剂治疗的RA患者中。中性粒细胞CD64水平的显着增加可能为结核病的诊断提供重要的见识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号